NCT07599176 Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors Status RECRUITING Phase PHASE1/PHASE2
NCT06831799 ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19 Status COMPLETED Phase N/A
NCT06772766 A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-dependent β-thalassemia Status RECRUITING Phase PHASE1
NCT06717932 A Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection Status ENROLLING_BY_INVITATION Phase N/A
NCT06685536 A Long-term Follow-up Study in Participants Who Received CS-101 Status ENROLLING_BY_INVITATION Phase N/A
NCT06647979 Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies Status RECRUITING Phase PHASE1
NCT06568926 Adherence of Beta Thalssemia Patients to Oral Chelation Therapy Status RECRUITING Phase NA
NCT06539169 FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases Status RECRUITING Phase N/A
NCT06509581 Vitamin E Supplementation for Children With Transfusion Dependent Beta Thalassemia on Different Iron Chelation Regimen Status COMPLETED Phase NA
NCT06490601 Long Term Beta Thalassemia Treatment: Findings From The Extension Period Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06479616 A Long-term Follow-up Study in Participants Who Received CS-101 Status RECRUITING Phase NA
NCT06364774 ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia Status RECRUITING Phase PHASE1/PHASE2
NCT06308159 An Open-label Study of a Gene Therapy Product (Vebeglogene Autotemcel) in Transfusion Dependent Beta-Thalassemia Status RECRUITING Phase PHASE1/PHASE2
NCT06271512 A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel Status RECRUITING Phase N/A
NCT06239389 Comparison Of Efficacy And Safety Of Thalidomide Vs Hydroxyurea In Thalassemia Patients: A Single-Centre Pilot Study. Status COMPLETED Phase PHASE2
NCT06065189 Base-edited Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With β-thalassemia Major Status COMPLETED Phase EARLY_PHASE1
NCT06024876 A Clinical Study Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemia Status COMPLETED Phase EARLY_PHASE1
NCT05635266 Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives Status RECRUITING Phase N/A